I-Adalimumab iwumuntu ngokugcwele, i-recombinant monoclonal antibody eqondise futhi ivimbe i-tumor necrosis factor-alpha (TNF-α), esiza ukunciphisa ukuvuvukala emzimbeni wonke. Abantu abane rheumatoid arthritis, i-psoriatic arthritis, i-ankylosing spondylitis, isifo sika-Crohn, kanye ne-ulcerative colitis ngokuvamile zithola ukukhululeka lapho zisebenzisa imijovo ye-adalimumab. Umuthi ulawula lezi zimo ze-autoimmune ngempumelelo kodwa awukwazi ukuzelapha ngokuphelele. Le ndatshana izochaza yonke into nge-adalimumab, okubandakanya ukusetshenziswa kwayo, umthamo kanye nezinyathelo zokuphepha ngaphambi kokuthatha lo muthi.
I-Adalimumab iyi-antibody ye-monoclonal yomuntu ngokugcwele. Umuthi uqondise i-tumor necrosis factor (TNF), iphrotheni ebhekele ukuvuvukala. Lo muthi osebenzayo uphatha izimo ezihlukahlukene zokuvuvukala.
Lo muthi welapha ukuvuvukala kwalokhu:
I-Adalimumab ifika ngamasirinji agcwaliswe ngaphambilini noma amapeni omjovo angena ngaphansi kwesikhumba. Isimo sakho nobudala bunquma umthamo. Abantu abadala abane-rheumatoid arthritis ngokuvamile badinga ama-40 mg njalo emavikini amabili.
Imiphumela emibi evamile yilezi:
Lo muthi uthola futhi uzinamathisele kuphrotheni ebizwa nge-tumor necrosis factor-alpha (TNF-alpha). Lapho i-TNF-alpha inamathela kuma-cell receptors, iqala ukuvuvukala emzimbeni wakho. Umuthi we-Adalimumab uvimba le phrotheni ukuthi inganamatheli kuma-receptors eseli lakho futhi ivimbe isignali yokuvuvukala.
Indlela ehlukile ye-Adalimumab iqondise kuphela i-TNF-alpha futhi ayithinti amanye ama-cytokines. Le ndlela ehlosiwe isiza ukunciphisa ukuvuvukala kwamalunga, ukuvuvukala kwesikhumba, nezinkinga zamathumbu.
Udinga ukuqaphela ngezinhlanganisela ezithile:
Udokotela wakho udinga ukwazi ngayo yonke imithi oyiphuzayo, kuhlanganisa naleyo yasezitolo. Qaphela ukuthi i-adalimumab ingase ibe nomthelela ekusebenzeni kwezidakamizwa ezithile ezinobubanzi obuncane bokuphepha (njenge-warfarin) emzimbeni wakho.
Isimo sakho sinquma umthamo:
Udokotela wakho uzolungisa le mithamo ngokusekelwe empendulweni yakho yokwelashwa.
I-Adalimumab iyindlela yokwelapha ephumelelayo ezigulini ezihlushwa yizimo zokuvuvukala zazo zonke izinhlobo. Lo muthi awukwazi ukwelapha lezi zifo, kodwa usebenza kahle ukuze ulawule izimpawu futhi uthuthukise ikhwalithi yempilo yezigidi zabantu emhlabeni wonke. Ungacabanga ngakho njengokhiye okhethekile oletha impumuzo ngokukhomba iphrotheni eyodwa nje evuvukalayo emzimbeni wakho.
Ukusabela komzimba wakho kulokhu kwelashwa kuzohluka. Udokotela wakho uzokwakha ishejuli yemithamo efanelana nesimo sakho—ungase uyidinga masonto onke noma njalo ngemva kweviki.
Lokhu kwelashwa kunemiphumela engemihle engaba khona, kodwa kunikeza ithemba kubantu ababezabalaza ngezinketho zokwelashwa ezilinganiselwe ngaphambili. Izinguqulo ze-Biosimilar zenze lokhu kwelashwa kutholakale kakhudlwana ezigulini emhlabeni wonke. I-Adalimumab isiza izinkulungwane zabantu ukuthi zibuyise ukulawula impilo yazo kanye nemisebenzi yansuku zonke—umjovo owodwa ohlosiwe ngesikhathi.
Umuthi ungaqeda amandla akho izivikeli mzimba futhi kukwenze ube sengozini enkulu yokuthola izifo. Ingozi yokutheleleka iphezulu uma ungaphezu kweminyaka engama-65. Umuthi futhi uza nengozi encane yomdlavuza othile, ikakhulukazi i-lymphoma ezigulini ezisencane. Abantu abanezimo zenhliziyo ezikhona bangase babone izinkinga zabo zenhliziyo ziba zimbi nakakhulu.
Intuthuko ibonakala endaweni ethile phakathi kwamaviki ama-2 kuya kwayi-12 ngemva kokuqala ukwelashwa. Ukuthi uphendula ngokushesha kangakanani kuncike esimweni sakho nezinye izici zempilo. Udinga ukuhlala ubekezele ngoba ezinye izimo zithatha isikhathi eside ukukhombisa inqubekelaphambili kunezinye.
Thatha umthamo ogejiwe ngokushesha nje lapho ukhumbula. Ngemva kwalokho, ungakwazi ukunamathela kushejuli yakho evamile yomjovo. Kodwa uma umthamo wakho olandelayo uyeza maduze, buza uchwepheshe wakho ukuthi enzeni. Ungazami ukubamba ngokuthatha umthamo ophindwe kabili.
Xhumana nodokotela wakho ngokushesha uma usola ukuthi kune-overdose noma unezimpawu ezinzima. Qiniseka ukuthi uza nephakethe lakho lemithi ukuze usize abasebenzi bezokwelapha banikeze ukwelashwa okufanele. Ungalindi ukuthi izimpawu zibe ngcono ngokwazo.
I-Adalimumab ayifanele uma:
Imiyalelo kadokotela wakho mayelana nesikhathi ibalulekile. Ukwelashwa kwe-arthritis ye-rheumatoid ngokuvamile kudinga imijovo njalo ngemva kweviki. Ukwelashwa kwesifo sika-Crohn kuqala ngemithamo ephezulu, bese kuthuthela emijovweni yokulungisa njalo ngemva kwamasonto amabili. Ukwelashwa kwe-Psoriasis kuqala ngomthamo wama-80mg futhi kuqhubeka njalo ngemva kwamasonto amabili.
Hlala ukhuluma nodokotela wakho ngaphambi kokumisa i-adalimumab. Ungase udinge ikhefu lesikhashana ngesikhathi sokutheleleka noma ngaphambi kokuhlinzwa. Iziguli ekululameni ngezinye izikhathi zinganciphisa umthamo wazo kancane kancane. Umuthi kungase kudingeke ukuthi umiswe okwesikhashana ngaphambi kwemithi ethile yokugoma.
I-Adalimumab inomphumela njengokwelashwa kwesikhathi eside. Kufanele uqhubeke uyithatha ngisho nalapho izimpawu zakho ziba ngcono ukuze ugcine ukulawula isimo sakho. Iziguli eziningi zibona ukuthuthuka emasontweni ambalwa ngemva kokuqala ukwelashwa. Udokotela wakho uzonquma ukuthi kufanele uqhubeke isikhathi esingakanani ngokusekelwe empendulweni yakho kanye nesimo esithile.
Ukusetshenziswa kwansuku zonke akunconyiwe. Udokotela wakho uzokunikeza i-adalimumab:
Ukuthatha imithamo evame kakhulu ngeke kuthuthukise imiphumela yakho futhi kungase kwenyuse ingcuphe yemiphumela engemihle.
Imihlahlandlela yezokwelapha ayicacisi "isikhathi esingcono kakhulu." Okubaluleke kakhulu ukunamathela esimisweni. Khetha usuku nesikhathi esifanelana neshejuli yakho ukuze sikusize ukhumbule indlela yakho yokujova kalula.
Hlala kude ne-: